FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Quarter Est. Return
1 Year Est. Return
+44.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$146M
AUM Growth
-$55.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$1.76M
2
+$861K
3
+$456K
4
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
+$57.3K

Top Sells

1
+$16.9M
2
+$14.1M
3
+$5.76M
4
XLRN
Acceleron Pharma
XLRN
+$4.26M
5
LRMR icon
Larimar Therapeutics
LRMR
+$3.97M

Sector Composition

1 Healthcare 58.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$42.9M 29.35%
3,967,900
-120,000
2
$21.3M 14.59%
2,814,883
3
$17.2M 11.73%
975,285
+25,913
4
$15M 10.26%
600,929
+70,513
5
$12.2M 8.34%
1,191,995
6
$9.17M 6.27%
727,857
+68,371
7
$8.6M 5.88%
1,054,864
-706,703
8
$4.55M 3.11%
63,337
-55,186
9
$4.18M 2.86%
900,155
+12,354
10
$3.75M 2.56%
428,989
-39,308
11
$2.33M 1.6%
542,756
-103,452
12
$1.66M 1.13%
48,839
-125,250
13
$1.35M 0.92%
83,211
-36,570
14
$1.25M 0.86%
156,741
15
$791K 0.54%
335,239
-408,156
16
– –
-16,991
17
– –
-33,718
18
– –
-264,583
19
– –
0